IMMUNOTHERAPY BRIDGE 2016
November 30th 2016
Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Sergio Bracarda
Azienda USL 8, Arezzo
Alfredo Budillon
National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Bruno Daniele
Azienda Ospedaliera G. Rummo Benevento
Sabino De Placido
University of Naples "Federico II", Naples, Italy
Cesare Gridelli
A.O.S.G. San Giuseppe Moscati, Avellino, Italy
Hans Hammers
UT Southwestern, Medical Center, Dallas, TX, USA
Vera Hirsh
McGill University Health Centre Cedars Cancer Centre, Montreal, Quebec
Joseph W. Kim
Yale School of Medicine, Yale
Lisa Licitra
Istituto Nazionale dei Tumori "Fondazione IRCCS", Milan, Italy
Rita Nanda
Section of Hematology - Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois
Graham Pawelec
Second Deperment of Internal Medicine, University of Tuebingen, Tuebingen, Germany
David Planchard
Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France
Sandro Pignata
National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
For information please contact info@melanomabridge.org
